MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers

Human Molecular Genetics

Volumn 8, Issue 4, 1999, Pages 661-666

  Simpkins, Sally B ^a   Bocker, Tina ^b   Swisher, Elizabeth M ^a   Mutch, David G ^a   Gersell, Deborah J ^a   Kovatich, Albert J ^b   Palazzo, Juan P ^b   Fishel, Richard ^b   Goodfellow, Paul J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA REPAIR; ENDOMETRIUM CANCER; FEMALE; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0032997736     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.4.661     Document Type: Article

References (30)

1. Parker, S.L., Tong, T., Bolden, S. and Wingo, P.A. (1996) Cancer statistics, 1996. CA Cancer J. Clin., 46, 5-27.
2. Watson, P. and Lynch, H.T. (1993) Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer, 71, 677-685.
3. Ignar-Trowbridge, D., Risinger, J.I., Dent, G.A., Kohler, M., Berchuck, A., McLachlan, J.A. and Boyd, J. (1992) Mutations of the Ki-ras oncogene in endometrial carcinoma. Am. J. Obset. Gynecol., 167, 227-232.
4. Enomoto, T., Fujita, M., Inoue, M., Rice, J.M., Nakajima, R., Tanizawa, O. and Nomura, T. (1993) Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premaJignant and malignant lesions of the human uterine endometrium. Cancer Res., 53, 1883-1888.
5. Fujimoto, I., Shimizu, Y., Hirai, Y., Chen, J.T., Teshima, H., Hasumi, K., Masubuchi, K. and Takahashi, M. (1993) Studies on ras oncogene activation in endometrial carcinoma. Gynecol. Oncol., 48, 196-202.
6. Honda, T., Kato, H., Imamura, T., Gima, T., Nishida, J.I., Sasaki, M., Hoshi, K., Sato, A. and Wake, N. (1993) Involvement of p53 gene mutations in human endometrial carcinomas. Int. J. Cancer, 53, 963-967.
7. Risinger, J.I., Hayes, A.H., Berchuck, A. and Barrett, C. (1997) PTEN/ MMACl mutations in endometrial cancers. Cancer Res., 57, 4736-4738.
8. Kong, D., Suzuki, A., Zou, T.-T., Sakurada, A., Kemp, L.W., Wakatsuki, S., Yokoyama, T., Yamakawa, H., Furukawa, T., Sato, M., Ohuchi, N., Sato, S., Yin, J., Wang, S., Abraham, J.M., Souza, R.F., Smolinski, K.N., Meltzer, S.J. and Horii, A. (1997) PTENI is frequently mutated in primary endometrial carcinomas. Nature Genet., 17, 143-144.
9. Tashiro, H., Blazes, M.S., Wu, R., Cho, K.R., Bose, S., Wang, S.I., Li, J., Parsons, R. and Ellenson, L.H. (1997) Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res., 57, 3935-3940.
10. Burks, R.T., Kessis, T.D., Cho, K.R. and Hedrick, L. (1994) Microsatellite instability in endometrial carcinoma. Oncogene, 9, 1163-1166.
11. Risinger, J.I., Berchuck, A., Kohler, M.F., Watson, P., Lynch, H.T. and Boyd, J. (1993) Genetic instability of microsatellites in endometrial carcinoma. Cancer Res., 53, 5100-5103.
12. Peiffer, S.L., Herzog, T.J., Tribune, D.J., Mutch, D.G., Gersell, D.J. and Goodfellow, P.J. (1995) Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res., 55, 1922-1926.
13. + endometrial cancers. Genes Chromosomes Cancer, 18, 219-227.
14. Aaltonen, L.A., Peltomäki, P., Leach, F.S., Sistonen, P., Pylkkanen, L., Mecklin, J.P., Jarvinen, H., Powell, S.M., Jen, J., Hamilton, S.R., Petersen, G.M., Kinzler, K.W., Vogelstein, B. and de la Chapelle, A. (1993) Clues to the pathogenesis of familial colorectal cancer. Science, 260, 812-815.
15. Aaltonen, L.A., Peltomäki, P., Mecklin, J.P., Jarvinen, H., Jass, J.R., Green, J.S., Lynch, H.T., Watson, P., Tallqvist, G., Juhola, M., Sistonen, P., Hamilton, S.R., Kinzler, K.W., Vogelstein, B. and de la Chapelle, A. (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res., 54, 1645-1648.
16. Dietmaier, W., Wallinger, S., Bocker, T., Kullmann, F., Fishel, R. and Rushoff, J. (1997) Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res., 57, 4749-4756.
17. Peltomäki, P. and Vasen, H.F.A. (1997) Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. Gastroenterology, 113, 1146-1158.
18. Katabuchi, H., van Rees, B., Lambers, A.R., Ronnett, B.M., Blazes, M.S., Leach, F.S., Cho, K.R. and Hedrick, L. (1995) Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res., 55, 5556-5560.
19. Kobayashi, K., Matsushima, M., Koi, S., Saito, H., Sagae, S., Kudo, R. and Nakamura, Y. (1996) Mutational analysis of mismatch repair genes, hMLHI and hMSH2, in sporadic endometrial carcinomas with microsatellite instability. Jpn. J. Cancer Res., 87, 141-145.
20. Lim, P.C., Tester, D., Cliby, W., Ziesmer, S.C., Roche, P.C., Hartman, L., Thibodeau, S.N., Podratz, K.C. and Jenkins, R.B. (1996) Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability. Clin. Cancer Res., 2, 1907-1911.
21. Thibodeau, S.N., French, A.J., Roche, P.C., Cunningham, J.M., Tester, D.J., Lindor, N.M., Moslein, G., Baker, S.M., Liskay, R.M., Burgart, L.J., Honchel, R. and Halling, K.C. (1996) Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res., 56, 4836-4840.
22. Kane, M.F., Loda, M., Gaida, G.M., Lipman, J., Mishra, R., Goldman, H., Jessup, J.M. and Kolodner, R. (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLHI in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res., 57, 808-811.
23. Herman, J.G., Umar, A., Polyak, K., Graff, J.R., Ahuja, N., Issa, J.-P.J., Markowitz, S., Willson, J.K.V., Hamilton, S.R., Kinzler, K.W., Kane, M.F., Kolodner, R.D., Vogelstein, B., Kunkel, T.A. and Baylin, S.B. (1998) Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl Acad. Sci. USA, 95, 6870-6875.
24. Cunningham, J.M., Christensen, E.R., Tester, D.J., Kim, C.-Y., Roche, P.C., Burgart, L.J. and Thibodeau, S.N. (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res., 58, 3455-3460.
25. Veigl, M.L., Kasturi, L., Olechnowicz, J., Ma, A., Lutterbaugh, J.D., Periyasamy, S., Li, G.-M., Drummond, J., Modrich, P.L., Sedwick, W.D. and Markowitz, S.D. (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl Acad. Sci. USA, 95, 8698-8702.
26. Esteller, M., Levine, R., Baylin, S.B., Ellenson, L.H. and Herman, J.G. (1998) MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene, 16, 2413-2417.
27. Millar, A.L., Pal, T., Madlensky, L., Sherman, C., Gallinger, S., Bapat, B. and Narod, S. (1999) Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. Hum. Mol. Genet., submitted for publication.
28. Vasen, H.F.A., Wijnen, J.T., Menko, F.H., Kleibeuker, J.H., Taal, B.G., Griffioen, G., Nagengast, F.M., Meijers-Heijboer, E.H., Bertario, L., Varesco, L., Bisgaard, M.L., Johr, J., Fodde, R. and Khan, P.M. (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 110, 1020-1027.
29. Vasen, H.F.A., Mecklin, J.-P., Khan, P.M. and Lynch, H.T. (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis. Colon Rectum, 34, 424-425.
30. Swisher, E.M., Peiffer-Schneider, S., Mutch D.G., Herzog, T.J., Rader, J.S., Elbendary, A. and Goodfellow, P.J. (1999) Differences in the patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability. Cancer, 85, 119-126.